Linner Nova Earbud vs Otofonix Groove

The Linner Nova Earbud is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.4/5 in HearAdvisor lab testing. At $299, it ranks #39 of 65 OTC hearing aids tested, placing it in the top 58% of its category. This device shows a distinctive performance profile with clear strengths and weaknesses. Music streaming is a standout at 4.5/5—an excellent score that sits 2.58 points above the category average. Feedback handling is equally impressive at 5.0/5, meaning users can expect stable performance without whistling during normal wear. These metrics suggest the Linner Nova excels as a streaming-capable earbud-style device. However, speech clarity metrics fall below category averages. Speech in quiet scores 2.1/5, which is 0.71 points below average and reflects mixed absolute performance. Speech in noise is low at 1.3/5, trailing the average by 0.19 points. Own-voice comfort is particularly challenged at 0.5/5—a low score that sits 2.01 points below the category average, meaning users may notice their own voice sounds unnatural or boomy. The Linner Nova Earbud may appeal to buyers who prioritize streaming audio quality and stable feedback-free wear over maximum speech benefit. Those seeking stronger speech clarity should consider alternatives in this price range like the Elehear Beyond (4.34/5) or Apple AirPods Pro 2 (4.04/5), which score higher overall.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.